ReturnSafe, the Austin-based symptom checking and contact tracing health-management toolkit for businesses, has secured $3.25 million in finances from investors. Active Capital and Fifty Years are some of the investors that have funded ReturnSafe.
The New Year will see many businesses opening their offices to employees with safety protocols in place, and therefore, the demand for management toolkits that track employees’ health will be on the rise. WorkSafe, ProtectWell and NSpace are the other names in the tech market that are giving stiff competition to ReturnSafe.
Launched in May 2020, ReturnSafe today has a six-figure monthly revenue with its reach across 50 organisations globally. The Company initially banked on contact tracing and symptom tracking and has lately introduced vaccine management. This latest offering will allow companies to access vaccination records of employees they share with the employers.
Tarun Nimmagadda, CEO, ReturnSafe in a press release had stated that with the widespread availability of the COVID-19 vaccine on the horizon, businesses would need a tool to manage employees who have been vaccinated and those who need to be vaccinated, at least over the next two years.
With quarantine-management tools, provisions to check employees’ symptoms daily and ways to help companies log results quickly on a dashboard, such health-management platforms will become indispensable for companies. The fresh vaccine-manager feature of ReturnSafe aims to make it easier to monitor vaccine charts of employees.
Nimmagadda is also the founder of Mutual Mobile and the CEO of Ruckit, a construction equipment-management platform. He is also the executive director of CoronaTrace, which is a mobile initiative that brings together the tech community to fight COVID -19.